Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, Endocervical Curettage Test, and HPV Test), By Age Group (Age 20–40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023

Code : CMI3994

Pages :220

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Regional Analysis

Global Cervical Cancer Diagnostic Tests Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global cervical cancer diagnostic tests market over the forecast period owing to the increase in cervical cancer prevalence. For instance, on June 08, 2023, according to the Centers for Disease Control and Prevention, each year in the U.S., about 11,500 new cases of cervical cancer are diagnosed and about 4,000 women die of this cancer.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa